Global Epilepsy Monitoring Device Market to Hit USD 1272.2 Million, Globally By 2030 at 8.83% CAGR | Infinium Global Research

Infinium Global Research, a premier market research firm, has released a comprehensive report on the Global Epilepsy Monitoring Device Market. The report delves deep into market segments and sub-segments on both a global and regional scale, offering insights into the market's driving factors, constraints, and macro indicators. It presents trends, forecasts, and dollar values, addressing the current and future state of the global epilepsy monitoring device market. The global epilepsy monitoring device market was valued at USD 661.6 Million in 2022 and is expected to reach USD 1272.2 Million by 2030 and grow at a CAGR of 8.83% over the forecast period.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/18084

Rapid Growth Anticipated for Epilepsy Monitoring Device Market

The global epilepsy monitoring device market is poised for substantial growth, with an expected CAGR of 8.83% between 2023 and 2030 in terms of value. Epilepsy monitoring devices have become essential in diagnosing brain abnormalities. According to the Centers for Disease Control and Prevention, approximately 3.4 million Americans, including 470,000 children, live with epilepsy. Yet, roughly 35% of these individuals do not respond to medication to control seizures. Consequently, over the last few decades, a variety of devices, such as mHealth wearables and SmartWatches like Inspyre™ for the Apple Watch, have been introduced. These devices enable the tracking of epileptic seizures and provide alerts to care teams, enhancing patient safety. The rising global prevalence of epilepsy, with an estimated 50 million cases, increases the demand for epilepsy monitoring devices, reflecting the burden of seizure-related disability, stigma, mortality, comorbidities, and costs. Moreover, growing awareness about epilepsy and the increased use of monitoring devices are further propelling the market's growth.

Diagnostic Challenges and Technological Advancements Drive Market Dynamics

While the market is expanding, diagnostic challenges remain an obstacle for global epilepsy monitoring devices. Accurately diagnosing epilepsy is intricate because clinicians seldom have the opportunity to observe seizures, and the condition includes numerous types of seizures and epilepsy syndromes, each with distinctive appearances. However, technological advances in monitoring devices are providing opportunities for market players. Enhanced visualization of seizures through digital cameras with video capabilities and video monitoring in-home settings are particularly valuable for individuals with infrequent seizures or multiple seizure types. Such technological advancements have the potential to significantly impact treatment decisions and improve patient outcomes.

Geographical Insights

Geographically, North America claims the largest share of the global epilepsy monitoring device market. The region benefits from advanced healthcare facilities and a well-established healthcare infrastructure. With an estimated annual incidence of 150,000 new cases of epilepsy in the U.S., the region exhibits a growing prevalence of the condition. Asia-Pacific, on the other hand, is the fastest-growing region due to its large population and epilepsy prevalence.

Key Players in the Market

Leading players in the global epilepsy monitoring device market include Medtronic plc, Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, LivaNova, PLC, St. Jude Medical, Inc., Empatica Inc., and Boston Scientific Corporation.

Epilepsy - A Global Health Concern

Epilepsy is a noncommunicable chronic brain disorder affecting people of all ages. The World Health Organization (WHO) reports that epilepsy is one of the most common neurological diseases worldwide, with an estimated 50 million cases globally. The condition places a significant burden on healthcare systems due to seizure-related disability, stigma, mortality, comorbidities, and associated costs. According to the WHO, the proportion of people with active epilepsy at a given time ranges from 4 to 10 per 1,000 people, with higher proportions in low-income countries. Moreover, the International League against Epilepsy (ILAE) estimates that genetic factors account for around 30% of the causes in patients with epilepsy.

Advancements in Monitoring Devices for Better Management

A large portion of the population lives with epilepsy, and while there is no cure, effective management is possible through medications and precise monitoring. This has led to innovations by monitoring device manufacturers, enabling improved visualization of seizures and better tracking. Technological advancements, such as mHealth wearables and digital cameras with video capabilities, provide tools for quantifying seizures more reliably and improving treatment decisions. These devices are especially valuable for individuals with infrequent seizures or limited access to specialized care.

The Challenge of Accurate Diagnosis

Accurate diagnosis of epilepsy remains challenging, and the U.S. Food and Drug Administration (FDA) has approved a mHealth wearable that can detect epileptic seizures and alert care teams. Referral to epilepsy centers reveals that up to 40% of patients with a diagnosis of refractory epilepsy were misdiagnosed. Given that clinicians rarely have the opportunity to observe seizures, diagnosis is primarily based on patients' or family members' reports and medical history. Diagnostic tests, such as electroencephalograms (EEGs), provide information but rarely coincide with actual seizures. Addressing this diagnostic challenge is essential to reduce the burden of uncontrolled seizures, creating opportunities for further technological advancements in monitoring devices.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/18084

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Epilepsy Monitoring Device Market Highlights

2.2. Epilepsy Monitoring Device Market Projection

2.3. Epilepsy Monitoring Device Market Regional Highlights

Chapter 3. Global Epilepsy Monitoring Device Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product

3.4.2. IGR-Growth Matrix Analysis by End User

3.4.3. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Epilepsy Monitoring Device Market

Chapter 4. Epilepsy Monitoring Device Market Macro Indicator Analysis

Global Epilepsy Monitoring Device Market by Product
5.1. Conventional Devices

5.2. Wearable Devices

Chapter 6. Global Epilepsy Monitoring Device Market by End User

6.1. Clinics

6.2. Hospitals

6.3. Home Care Settings

6.4. Other End Users

Chapter 7. Global Epilepsy Monitoring Device Market by Region 2023-2030

7.1. North America

7.1.1. North America Epilepsy Monitoring Device Market by Product

7.1.2. North America Epilepsy Monitoring Device Market by End User

7.1.3. North America Epilepsy Monitoring Device Market by Country

7.2. Europe

7.2.1. Europe Epilepsy Monitoring Device Market by Product

7.2.2. Europe Epilepsy Monitoring Device Market by End User

7.2.3. Europe Epilepsy Monitoring Device Market by Country

7.3. Asia-Pacific

7.3.1. Asia-Pacific Epilepsy Monitoring Device Market by Product

7.3.2. Asia-Pacific Epilepsy Monitoring Device Market by End User

7.3.3. Asia-Pacific Epilepsy Monitoring Device Market by Country

7.4. RoW

7.4.1. RoW Epilepsy Monitoring Device Market by Product

7.4.2. RoW Epilepsy Monitoring Device Market by End User

7.4.3. RoW Epilepsy Monitoring Device Market by Sub-region

Chapter 8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global Epilepsy Monitoring Device Market

8.2. Companies Profiles

8.2.1. Medtronic plc

8.2.2. Koninklijke Philips N.V.

8.2.3. Natus Medical Incorporated

8.2.4. Nihon Kohden Corporation

8.2.5. LivaNova, PLC

8.2.6. St. Jude Medical, Inc.

8.2.7. Empatica Inc.

8.2.8. Boston Scientific Corporation

Chapter 9. Appendix

9.1. Primary Research Findings and Questionnaire

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/18084

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of epilepsy monitoring device.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.